The protective MBL2 haplotype LYQC, which is virtually unique to sub-Saharan Africa and occurs there at high frequencies, might have been selected for, because it confers, with a significant odds ratio, protection from clinical TB caused by M. africanum/M. The gene discussed is MBL2; the disease is tuberculosis.